India is at a key inflexion point of not just ‘Heal in India’ through its vibrant medical value tourism, but also ‘Heal by India’, where our medical professionals can be used to serve not just our country but at the global level.
68% of patients receiving Kymriah in the ELARA trial experienced a complete response, with an 86% overall response rate, along with a remarkable safety profile
The campaign aims to promote an integrated view by combining Ayurveda and Yoga to create harmony not just within the body, but also in our minds
The groundbreaking SPF technology is specifically designed and formulated to prevent sunburn or sun damage while allowing the passage of sufficient UVB light that our bodies use to naturally produce vitamin D
The centre works with active pharmaceutical ingredients (APIs) and can utilize innovative concepts with model APIs
New block enhances the company's global capabilities in Oral Solid Dosage (OSD) Forms, increasing total plant capacity to 4.5 billion doses
Successfully removed peanut from the child’s left lung through bronchoscopy
The vaccine was found to have 64% efficacy against symptomatic disease and 92% against severe Covid-19
India has the second-largest number of adults with diabetes globally, after China
The plant is expected to start commercial operations from Q4FY24
Subscribe To Our Newsletter & Stay Updated
